XML 37 R26.htm IDEA: XBRL DOCUMENT
v3.22.2

Earnings per Common Share (Tables) | 6 Months Ended
--- | ---
Jun. 30, 2022
Earnings Per Share [Abstract] |
Schedule of Computation of Basic and Diluted Earnings Per Common Share | The following table sets forth the computation of basic and diluted earnings per common share (in millions, except per share amounts):
| Three Months Ended June 30, |  | Six Months Ended June 30,
| 2022 |  | 2021 |  | 2022 |  | 2021
Basic: |  |  |  |  |  |  |
Numerator: |  |  |  |  |  |  |
Income from continuing operations | $ | 71.3 |  |  | $ | 142.3 |  |  | $ | 181.4 |  |  | $ | 275.1 |
Less: Net income attributable to noncontrolling interests included in continuing operations | (22.6) |  |  | (28.7) |  |  | (45.2) |  |  | (54.2) |
Less: Income allocated to participating securities | (0.1) |  |  | (0.5) |  |  | (0.5) |  |  | (1.0) |
Income from continuing operations attributable to Encompass Health common shareholders | 48.6 |  |  | 113.1 |  |  | 135.7 |  |  | 219.9 |
Loss from discontinued operations, net of tax, attributable to Encompass Health common shareholders | — |  |  | (0.3) |  |  | — |  |  | (0.3) |
Net income attributable to Encompass Health common shareholders | $ | 48.6 |  |  | $ | 112.8 |  |  | $ | 135.7 |  |  | $ | 219.6 |
Denominator: |  |  |  |  |  |  |
Basic weighted average common shares outstanding | 99.2 |  |  | 99.0 |  |  | 99.2 |  |  | 99.0 |
Basic earnings per share attributable to Encompass Health common shareholders: |  |  |  |  |  |  |
Continuing operations | $ | 0.49 |  |  | $ | 1.14 |  |  | $ | 1.37 |  |  | $ | 2.22 |
Discontinued operations | — |  |  | — |  |  | — |  |  | — |
Net income | $ | 0.49 |  |  | $ | 1.14 |  |  | $ | 1.37 |  |  | $ | 2.22 |
Diluted: |  |  |  |  |  |  |
Numerator: |  |  |  |  |  |  |
Income from continuing operations | $ | 71.3 |  |  | $ | 142.3 |  |  | $ | 181.4 |  |  | $ | 275.1 |
Less: Net income attributable to noncontrolling interests included in continuing operations | (22.6) |  |  | (28.7) |  |  | (45.2) |  |  | (54.2) |
Income from continuing operations attributable to Encompass Health common shareholders | 48.7 |  |  | 113.6 |  |  | 136.2 |  |  | 220.9 |
Loss from discontinued operations, net of tax, attributable to Encompass Health common shareholders | — |  |  | (0.3) |  |  | — |  |  | (0.3) |
Net income attributable to Encompass Health common shareholders | $ | 48.7 |  |  | $ | 113.3 |  |  | $ | 136.2 |  |  | $ | 220.6 |
Denominator: |  |  |  |  |  |  |
Diluted weighted average common shares outstanding | 100.3 |  |  | 100.2 |  |  | 100.2 |  |  | 100.2 |
Diluted earnings per share attributable to Encompass Health common shareholders: |  |  |  |  |  |  |
Continuing operations | $ | 0.49 |  |  | $ | 1.13 |  |  | $ | 1.36 |  |  | $ | 2.20 |
Discontinued operations | — |  |  | — |  |  | — |  |  | — |
Net income | $ | 0.49 |  |  | $ | 1.13 |  |  | $ | 1.36 |  |  | $ | 2.20 |
Schedule of Reconciliation of Weighted Average Number of Shares Outstanding | The following table sets forth the reconciliation between basic weighted average common shares outstanding and diluted weighted average common shares outstanding (in millions):
| Three Months Ended June 30, |  | Six Months Ended June 30,
| 2022 |  | 2021 |  | 2022 |  | 2021
Basic weighted average common shares outstanding | 99.2 |  |  | 99.0 |  |  | 99.2 |  |  | 99.0 |
Restricted stock awards, dilutive stock options, and restricted stock units | 1.1 |  |  | 1.2 |  |  | 1.0 |  |  | 1.2 |
Diluted weighted average common shares outstanding | 100.3 |  |  | 100.2 |  |  | 100.2 |  |  | 100.2 |

X
- References No definition available. + Details
Name: | us-gaap_EarningsPerShareAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Publisher FASB -Name Accounting Standards Codification -Topic 260 -SubTopic 10 -Section 50 -Paragraph 1 -Subparagraph (a) -URI https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257 + Details
Name: | us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the weighted average number of shares used in calculating basic net earnings per share (or unit) and diluted earnings per share (or unit). + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 260 -SubTopic 10 -Section 50 -Paragraph 1 -URI https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257 + Details
Name: | us-gaap_ScheduleOfWeightedAverageNumberOfSharesTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration